We just received data on a new analyst forecast for $CDTX. HC Wainwright & Co. gave a rating of 'Buy' for $CDTX.
$CDTX Analyst Ratings
Wall Street analysts have issued reports on $CDTX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 10/21/2025
- Morgan Stanley issued a "Overweight" rating on 10/16/2025
- JP Morgan issued a "Overweight" rating on 10/10/2025
- WBB Securities issued a "Strong Buy" rating on 10/09/2025
- JMP Securities issued a "Market Outperform" rating on 10/03/2025
- Guggenheim issued a "Buy" rating on 09/25/2025
- RBC Capital issued a "Outperform" rating on 06/24/2025
To track analyst ratings and price targets for $CDTX, check out Quiver Quantitative's $CDTX forecast page.
$CDTX Price Targets
Multiple analysts have issued price targets for $CDTX recently. We have seen 10 analysts offer price targets for $CDTX in the last 6 months, with a median target of $158.5.
Here are some recent targets:
- Sara Nik from HC Wainwright & Co. set a target price of $150.0 on 10/21/2025
- Maxwell Skor from Morgan Stanley set a target price of $190.0 on 10/16/2025
- Anupam Rama from JP Morgan set a target price of $200.0 on 10/10/2025
- Steve Brozak from WBB Securities set a target price of $199.0 on 10/09/2025
- Roy Buchanan from JMP Securities set a target price of $173.0 on 10/03/2025
- Seamus Fernandez from Guggenheim set a target price of $167.0 on 09/25/2025
- Joseph Stringer from Needham set a target price of $100.0 on 09/24/2025
$CDTX Insider Trading Activity
$CDTX insiders have traded $CDTX stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CDTX stock by insiders over the last 6 months:
- CAPITAL MANAGEMENT, L.P. RA purchased 2,272,727 shares for an estimated $99,999,988
- CHRYSA MINEO has made 2 purchases buying 3,320 shares for an estimated $73,895 and 0 sales.
- NICOLE NEGAR DAVARPANAH (Chief Medical Officer) sold 474 shares for an estimated $29,796
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CDTX Hedge Fund Activity
We have seen 99 institutional investors add shares of $CDTX stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. added 2,272,727 shares (+208.0%) to their portfolio in Q2 2025, for an estimated $110,704,532
- BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC added 1,797,600 shares (+255.7%) to their portfolio in Q2 2025, for an estimated $87,561,096
- POINT72 ASSET MANAGEMENT, L.P. added 1,414,075 shares (+1242.0%) to their portfolio in Q2 2025, for an estimated $68,879,593
- BLACKROCK, INC. added 1,054,772 shares (+1994.0%) to their portfolio in Q2 2025, for an estimated $51,377,944
- MORGAN STANLEY added 875,198 shares (+10651.1%) to their portfolio in Q2 2025, for an estimated $42,630,894
- DARWIN GLOBAL MANAGEMENT, LTD. added 768,424 shares (+inf%) to their portfolio in Q2 2025, for an estimated $37,429,933
- VIVO CAPITAL, LLC added 627,149 shares (+91.7%) to their portfolio in Q2 2025, for an estimated $30,548,427
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
